Twenty U.S. states including California, Connecticut and Michigan have pushed back against a $10 million settlement that Florida reached with Swiss generic drugmaker Sandoz, saying a key provision ...

This leaflet answers some common questions about Cyclosporin Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...

Sandoz will eventually transfer manufacturing ... the drugmaker decided the pursuit of new drugs that might help stem the rising tide in antimicrobial resistance (AMR) was too challenging, joining ...

with 500 million patients across more than 100 countries treated with Sandoz drugs. Generics and biosimilars account for an estimated 80% of medicines used worldwide by volume, at about 25% of the ...

Osteoporosis drug Prolia faces intense competition as patents expire and generics launch Intense rivalry emerges in the ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

After rising to prominence during the COVID-19 pandemic, South African drugmaker Aspen Pharmacare has landed in the FDA's ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

B.C. government B.C. Supreme Court opioid case against pharmaceutical companies can move ahead, appeal court rules in ...

distribution or sale of opioid drugs and products from 1996 to the present,” Justice Michael Brundrett said in a 2023 decision. “Generally, the plaintiff’s claim against the manufacturer ...